دورية أكاديمية

Role of pattern recognition receptors in sensing Mycobacterium tuberculosis .

التفاصيل البيبلوغرافية
العنوان: Role of pattern recognition receptors in sensing Mycobacterium tuberculosis .
المؤلفون: Zihad SMNK; Department of Pharmacy, State University of Bangladesh, Dhaka, 1205, Bangladesh., Sifat N; Department of Pharmacy, ASA University of Bangladesh, Dhaka, 1207, Bangladesh., Islam MA; Department of Pharmacy, University of Asia Pacific, Dhaka, 1205, Bangladesh., Monjur-Al-Hossain ASM; Department of Pharmaceutical Technology, University of Dhaka, Dhaka, 1000, Bangladesh., Sikdar KMYK; Department of Pharmaceutical Technology, University of Dhaka, Dhaka, 1000, Bangladesh., Sarker MMR; Department of Pharmacy, State University of Bangladesh, Dhaka, 1205, Bangladesh.; Department of Pharmacy, Gono University, Nolam, Mirzanagar, Savar, Dhaka 1344, Bangladesh., Shilpi JA; Pharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh., Uddin SJ; Pharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.
المصدر: Heliyon [Heliyon] 2023 Oct 04; Vol. 9 (10), pp. e20636. Date of Electronic Publication: 2023 Oct 04 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : Elsevier Ltd, [2015]-
مستخلص: Mycobacterium tuberculosis is one of the major invasive intracellular pathogens causing most deaths by a single infectious agent. The interaction between host immune cells and this pathogen is the focal point of the disease, Tuberculosis. Host immune cells not only mount the protective action against this pathogen but also serve as the primary niche for growth. Thus, recognition of this pathogen by host immune cells and following signaling cascades are key dictators of the disease state. Immune cells, mainly belonging to myeloid cell lineage, recognize a wide variety of Mycobacterium tuberculosis ligands ranging from carbohydrate and lipids to proteins to nucleic acids by different membrane-bound and soluble pattern recognition receptors. Simultaneous interaction between different host receptors and pathogen ligands leads to immune-inflammatory response as well as contributes to virulence. This review summarizes the contribution of pattern recognition receptors of host immune cells in recognizing Mycobacterium tuberculosis and subsequent initiation of signaling pathways to provide the molecular insight of the specific Mtb ligands interacting with specific PRR, key adaptor molecules of the downstream signaling pathways and the resultant effector functions which will aid in identifying novel drug targets, and developing novel drugs and adjuvants.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2023 The Authors.)
References: J Biol Chem. 2014 Oct 24;289(43):30052-62. (PMID: 25202022)
Clin Dev Immunol. 2011;2011:405310. (PMID: 21603213)
EMBO Rep. 2021 Jul 5;22(7):e51678. (PMID: 33987949)
J Exp Med. 2009 Sep 28;206(10):2205-20. (PMID: 19770268)
EMBO J. 2008 Jan 23;27(2):373-83. (PMID: 18079694)
Cytokine. 2017 Feb;90:38-43. (PMID: 27768958)
Cell Microbiol. 2010 Nov;12(11):1648-65. (PMID: 20560977)
Immunity. 2007 May;26(5):605-16. (PMID: 17462920)
Nat Immunol. 2003 Jul;4(7):702-7. (PMID: 12796777)
Front Immunol. 2022 Mar 28;13:862992. (PMID: 35418999)
Front Cell Infect Microbiol. 2012 Nov 23;2:145. (PMID: 23189273)
Clin Exp Immunol. 2014 Nov;178(2):310-9. (PMID: 25041480)
Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S69-74. (PMID: 22088322)
Adv Exp Med Biol. 2012;946:21-36. (PMID: 21948360)
BMC Infect Dis. 2017 Jul 11;17(1):488. (PMID: 28693442)
Infect Genet Evol. 2016 Apr;39:92-98. (PMID: 26774366)
Glycobiology. 2009 Dec;19(12):1473-84. (PMID: 19684355)
J Lipid Res. 2005 Mar;46(3):475-83. (PMID: 15576843)
Immunity. 2014 Dec 18;41(6):898-908. (PMID: 25526305)
Infect Immun. 2011 Mar;79(3):1077-85. (PMID: 21199913)
Front Immunol. 2021 Jul 12;12:696491. (PMID: 34322125)
Innate Immun. 2016 Apr;22(3):181-5. (PMID: 26939595)
J Mol Biol. 2018 Jan 19;430(2):217-237. (PMID: 28987733)
Annu Rev Immunol. 2012;30:491-529. (PMID: 22224766)
Cell Microbiol. 2013 Sep;15(9):1484-95. (PMID: 23795683)
BMC Infect Dis. 2018 Nov 13;18(1):561. (PMID: 30424735)
J Immunol Res. 2015;2015:747543. (PMID: 26258152)
Front Immunol. 2015 Jun 11;6:306. (PMID: 26124759)
Infect Immun. 2007 Nov;75(11):5127-34. (PMID: 17709422)
J Immunol. 2015 Apr 15;194(8):3756-67. (PMID: 25780035)
Cell Mol Immunol. 2017 Dec;14(12):963-975. (PMID: 28890547)
J Biol Chem. 2013 Aug 23;288(34):24956-71. (PMID: 23846686)
J Biol Chem. 2017 Jun 23;292(25):10685-10695. (PMID: 28442574)
PLoS Pathog. 2023 Jun 23;19(6):e1011088. (PMID: 37352334)
Tuberculosis (Edinb). 2018 Jul;111:170-177. (PMID: 30029904)
PLoS Med. 2006 Feb;3(2):e20. (PMID: 16379498)
J Immunol. 2004 Apr 1;172(7):4425-34. (PMID: 15034058)
J Immunol. 2016 Dec 15;197(12):4727-4735. (PMID: 27913648)
PLoS One. 2017 Apr 6;12(4):e0174973. (PMID: 28384255)
Mucosal Immunol. 2017 Jul;10(4):1069-1081. (PMID: 28247861)
Clin Dev Immunol. 2012;2012:193923. (PMID: 22666281)
Infect Immun. 2001 Dec;69(12):7349-55. (PMID: 11705907)
Sci Rep. 2020 Feb 28;10(1):3709. (PMID: 32111888)
J Leukoc Biol. 2008 Jul;84(1):115-23. (PMID: 18443188)
J Immunol. 1995 Dec 1;155(11):5343-51. (PMID: 7594549)
Tuberculosis (Edinb). 2016 Jul;99:1-10. (PMID: 27449998)
Infect Immun. 2009 Oct;77(10):4529-37. (PMID: 19620350)
Sci Rep. 2018 Nov 15;8(1):16840. (PMID: 30443026)
J Immunol Res. 2016;2016:3845247. (PMID: 27413759)
J Clin Invest. 2004 Dec;114(12):1699-703. (PMID: 15599394)
Nature. 2000 Dec 7;408(6813):740-5. (PMID: 11130078)
J Clin Immunol. 2009 Jan;29(1):46-56. (PMID: 18690522)
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2675-2680. (PMID: 28223515)
J Immunol. 2019 Nov 15;203(10):2665-2678. (PMID: 31619537)
Front Immunol. 2016 Sep 27;7:386. (PMID: 27729911)
Front Cell Infect Microbiol. 2022 May 02;12:862582. (PMID: 35586249)
PLoS One. 2013 Nov 04;8(11):e79670. (PMID: 24223991)
Microbiol Immunol. 2003;47(11):841-7. (PMID: 14638995)
Tuberculosis (Edinb). 2018 Jul;111:67-70. (PMID: 30029917)
Exp Cell Res. 2017 Mar 15;352(2):313-321. (PMID: 28215633)
Front Immunol. 2020 Jul 16;11:1230. (PMID: 32765485)
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2997-3006. (PMID: 23882081)
Nature. 2012 Apr 25;484(7395):510-3. (PMID: 22538615)
Nat Commun. 2017 Jul 11;8:16035. (PMID: 28695899)
J Immunol. 2012 Feb 1;188(3):1019-26. (PMID: 22227568)
BMC Pulm Med. 2015 May 08;15:57. (PMID: 25948535)
Nat Rev Microbiol. 2010 Apr;8(4):296-307. (PMID: 20234378)
J Investig Med. 1996 Aug;44(6):312-23. (PMID: 8795295)
Eur J Microbiol Immunol (Bp). 2011 Mar;1(1):25-40. (PMID: 24466434)
Genet Mol Res. 2013 Oct 24;12(4):4918-24. (PMID: 24301751)
Int J Infect Dis. 2014 Sep;26:31-6. (PMID: 24984162)
Tuberculosis (Edinb). 2019 May;116:22-31. (PMID: 31153514)
J Histochem Cytochem. 2006 Jul;54(7):763-71. (PMID: 16517975)
J Exp Med. 2003 Jan 6;197(1):7-17. (PMID: 12515809)
Front Cell Infect Microbiol. 2018 Mar 27;8:95. (PMID: 29637049)
J Mol Med (Berl). 2015 Jun;93(6):645-62. (PMID: 25586105)
PLoS Pathog. 2019 Apr 18;15(4):e1007724. (PMID: 30998773)
Microb Pathog. 2011 Jun;50(6):350-9. (PMID: 21419839)
Biosci Rep. 2018 Feb 2;38(1):. (PMID: 29298876)
J Immunol. 2002 Feb 1;168(3):1309-14. (PMID: 11801670)
Sci Rep. 2016 Jan 12;6:19084. (PMID: 26754352)
PLoS One. 2013;8(1):e53531. (PMID: 23308247)
Nature. 2014 Aug 28;512(7515):387-92. (PMID: 25119038)
Immunology. 2008 Oct;125(2):272-9. (PMID: 18393969)
J Immunol. 2018 Feb 1;200(3):1016-1026. (PMID: 29255077)
Elife. 2020 Mar 05;9:. (PMID: 32134383)
PLoS One. 2009 Jun 05;4(6):e5810. (PMID: 19503839)
J Cell Biochem. 2017 Dec;118(12):4222-4229. (PMID: 28419514)
Immunity. 2013 Jun 27;38(6):1142-53. (PMID: 23809161)
Sci Transl Med. 2011 Oct 12;3(104):104ra102. (PMID: 21998409)
J Immunol. 2017 Jun 15;198(12):4772-4780. (PMID: 28507027)
Infect Genet Evol. 2016 Jul;41:16-20. (PMID: 27012150)
J Immunol. 2017 May 15;198(10):3775-3789. (PMID: 28483986)
Mol Immunol. 2017 Jul;87:240-248. (PMID: 28514713)
J Immunol. 2018 May 1;200(9):3244-3258. (PMID: 29610140)
Infect Immun. 2006 May;74(5):2686-96. (PMID: 16622205)
J Leukoc Biol. 2010 Aug;88(2):227-32. (PMID: 20299682)
PLoS Genet. 2008 Oct;4(10):e1000218. (PMID: 18927625)
Apoptosis. 2015 Mar;20(3):358-70. (PMID: 25544271)
Nat Commun. 2015 Mar 17;6:6442. (PMID: 25778803)
J Immunol. 2013 Oct 1;191(7):3514-8. (PMID: 23997220)
Tuberculosis (Edinb). 2016 May;98:125-31. (PMID: 27156628)
Cytokine Growth Factor Rev. 2019 Aug;48:24-31. (PMID: 31296363)
J Immunol. 2008 May 15;180(10):6836-45. (PMID: 18453604)
Nat Immunol. 2007 Jun;8(6):610-8. (PMID: 17486091)
J Innate Immun. 2009;1(1):29-45. (PMID: 20375564)
J Immunol. 2015 Sep 1;195(5):2417-28. (PMID: 26202982)
Lung. 2016 Oct;194(5):763-7. (PMID: 27363694)
Cell Res. 2015 Dec;25(12):1333-51. (PMID: 26482950)
PLoS Pathog. 2009 Jun;5(6):e1000474. (PMID: 19521507)
Front Immunol. 2019 May 28;10:1142. (PMID: 31231363)
J Immunol. 2010 Jun 15;184(12):7057-70. (PMID: 20488784)
Cell Signal. 2014 May;26(5):942-50. (PMID: 24462705)
PLoS One. 2022 Sep 1;17(9):e0273517. (PMID: 36048884)
J Biol Chem. 2012 Jul 27;287(31):25964-74. (PMID: 22689578)
Tuberculosis (Edinb). 2017 Sep;106:16-24. (PMID: 28802400)
J Infect Dis. 2016 Dec 1;214(11):1629-1637. (PMID: 27630197)
Cell Microbiol. 2011 Mar;13(3):402-18. (PMID: 21040358)
Am J Pathol. 2004 Jan;164(1):49-57. (PMID: 14695318)
Respirology. 2012 Jul;17(5):847-53. (PMID: 22553928)
J Biol Chem. 2005 Jun 3;280(22):20961-7. (PMID: 15809303)
PLoS One. 2012;7(3):e34148. (PMID: 22493658)
Eur J Immunol. 2015 Jul;45(7):1957-71. (PMID: 25907170)
Cell Microbiol. 2016 Jun;18(6):875-86. (PMID: 26709456)
BMC Infect Dis. 2012 Apr 14;12:91. (PMID: 22502597)
Front Immunol. 2018 Mar 09;9:471. (PMID: 29662482)
J Infect Dis. 2008 Jun 15;197(12):1713-6. (PMID: 18419343)
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):679-91. (PMID: 9517576)
BMC Infect Dis. 2017 Mar 15;17(1):210. (PMID: 28298186)
PLoS Pathog. 2012;8(4):e1002614. (PMID: 22496642)
Microbes Infect. 2011 Feb;13(2):198-201. (PMID: 21034845)
iScience. 2019 Jan 25;11:13-30. (PMID: 30572206)
FEBS Lett. 2010 Jun 3;584(11):2445-54. (PMID: 20416295)
Sci Rep. 2019 Feb 28;9(1):3126. (PMID: 30816317)
Immunobiology. 2016 Jan;221(1):70-5. (PMID: 26255090)
Infect Immun. 2012 Oct;80(10):3343-59. (PMID: 22825450)
Nature. 2009 Mar 26;458(7237):514-8. (PMID: 19158675)
J Leukoc Biol. 2004 Feb;75(2):163-89. (PMID: 14525967)
J Immunol. 2004 Aug 15;173(4):2660-8. (PMID: 15294983)
Nat Commun. 2016 Apr 18;7:11322. (PMID: 27089465)
Exp Mol Med. 2018 Feb 5;50(2):e439. (PMID: 29400702)
PLoS One. 2013 Jun 26;8(6):e67277. (PMID: 23840651)
BMC Infect Dis. 2010 Oct 15;10:299. (PMID: 20950462)
Curr Drug Targets. 2008 Feb;9(2):102-12. (PMID: 18288961)
Sci Rep. 2017 Aug 1;7(1):7083. (PMID: 28765651)
Eur J Immunol. 2016 Feb;46(2):381-9. (PMID: 26558717)
Nat Immunol. 2015 Mar;16(3):237-45. (PMID: 25642820)
Cell Host Microbe. 2015 Feb 11;17(2):252-9. (PMID: 25674984)
Infect Genet Evol. 2012 Jun;12(4):732-6. (PMID: 22027159)
Infect Immun. 2001 Mar;69(3):1722-8. (PMID: 11179349)
Immunity. 2013 May 23;38(5):1050-62. (PMID: 23602766)
Microb Pathog. 2003 Sep;35(3):125-31. (PMID: 12927520)
J Immunol. 2009 Nov 15;183(10):6269-81. (PMID: 19880448)
Immunity. 2011 Dec 23;35(6):1023-34. (PMID: 22195750)
mBio. 2019 Aug 27;10(4):. (PMID: 31455656)
Infect Immun. 2011 Mar;79(3):1118-23. (PMID: 21173309)
Front Immunol. 2018 Jun 12;9:1123. (PMID: 29946317)
Trends Immunol. 2017 Jan;38(1):66-76. (PMID: 27889398)
APMIS. 2009 May;117(5-6):440-57. (PMID: 19400867)
BMC Infect Dis. 2019 Nov 28;19(1):1006. (PMID: 31779590)
J Immunol. 2008 Nov 15;181(10):7157-65. (PMID: 18981137)
Cell Host Microbe. 2008 Apr 17;3(4):224-32. (PMID: 18407066)
Front Immunol. 2018 Jul 02;9:1543. (PMID: 30013576)
J Immunol. 2015 Jun 1;194(11):5366-74. (PMID: 25888641)
J Innate Immun. 2016;8(3):228-42. (PMID: 26613532)
Microb Pathog. 2018 Jan;114:219-224. (PMID: 29180292)
Physiol Rev. 2015 Jan;95(1):149-78. (PMID: 25540141)
Nat Commun. 2020 May 8;11(1):2270. (PMID: 32385301)
Front Cell Infect Microbiol. 2018 May 25;8:171. (PMID: 29888212)
Mol Immunol. 2020 May;121:118-126. (PMID: 32199211)
Infect Immun. 1995 Apr;63(4):1598-602. (PMID: 7534279)
Sci Rep. 2017 Nov 8;7(1):15010. (PMID: 29118429)
Curr Top Microbiol Immunol. 2020;429:103-115. (PMID: 32300915)
Front Immunol. 2021 Jul 27;12:706081. (PMID: 34386011)
mBio. 2021 Aug 31;12(4):e0187120. (PMID: 34225486)
Nat Immunol. 2009 Oct;10(10):1081-8. (PMID: 19718030)
J Exp Med. 2005 Dec 19;202(12):1715-24. (PMID: 16365150)
Front Immunol. 2018 Jun 21;9:1427. (PMID: 29977244)
Front Immunol. 2018 Feb 15;9:227. (PMID: 29497419)
Gene. 2019 Aug 20;710:24-29. (PMID: 31075410)
J Exp Med. 2009 Dec 21;206(13):2879-88. (PMID: 20008526)
Mol Cell. 2012 Jun 29;46(6):746-58. (PMID: 22607974)
Autophagy. 2020 Jun;16(6):1021-1043. (PMID: 31462144)
Microbes Infect. 2016 Jul-Aug;18(7-8):505-9. (PMID: 27005451)
Infect Immun. 2018 Sep 21;86(10):. (PMID: 30037791)
Clin Chem Lab Med. 2002 Oct;40(10):1002-8. (PMID: 12476938)
Mol Biol Rep. 2014 Aug;41(8):5449-57. (PMID: 24874302)
Int Rev Cytol. 1999;187:203-59. (PMID: 10212981)
Nat Immunol. 2010 Jan;11(1):55-62. (PMID: 19898471)
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E540-E549. (PMID: 28069953)
Microbes Infect. 2019 Jan - Feb;21(1):40-49. (PMID: 29981934)
Immunol Cell Biol. 2014 Oct;92(9):741-6. (PMID: 24983458)
Eur J Immunol. 2012 Apr;42(4):880-9. (PMID: 22531915)
J Infect Dis. 2009 Mar 1;199(5):666-72. (PMID: 19199550)
Curr Opin Immunol. 2012 Aug;24(4):398-404. (PMID: 22677577)
Biomed Res Int. 2019 Jan 13;2019:2628101. (PMID: 30733958)
J Clin Invest. 2021 Sep 1;131(17):. (PMID: 34623322)
Front Immunol. 2018 Feb 13;9:225. (PMID: 29487599)
Immunology. 2012 Jun;136(2):231-40. (PMID: 22385341)
Microb Pathog. 2005 Sep;39(3):97-107. (PMID: 16098710)
Cell Microbiol. 2007 May;9(5):1087-98. (PMID: 17359235)
Immunity. 2009 Jun 19;30(6):789-801. (PMID: 19464198)
Infect Immun. 2015 Jun;83(6):2242-54. (PMID: 25776754)
PLoS Pathog. 2017 Jun 22;13(6):e1006333. (PMID: 28640912)
ACS Chem Biol. 2019 Mar 15;14(3):405-414. (PMID: 30735346)
PLoS One. 2009 Dec 24;4(12):e8448. (PMID: 20041149)
Mediators Inflamm. 2017;2017:2432904. (PMID: 28642632)
PLoS Pathog. 2011 Nov;7(11):e1002378. (PMID: 22102818)
Hum Immunol. 2011 Feb;72(2):183-6. (PMID: 21081145)
Cell Mol Immunol. 2016 Nov;13(6):729-746. (PMID: 26166760)
Immunity. 2014 Sep 18;41(3):402-413. (PMID: 25176311)
Nat Rev Immunol. 2018 Jun;18(6):374-389. (PMID: 29581532)
Cells. 2015 May 22;4(2):178-201. (PMID: 26010753)
Pathogens. 2018 Feb 27;7(1):. (PMID: 29495442)
Sci Rep. 2018 Sep 3;8(1):13129. (PMID: 30177769)
Nature. 2016 Feb 18;530(7590):354-7. (PMID: 26814970)
J Immunol. 2020 Feb 1;204(3):671-681. (PMID: 31871022)
PLoS Pathog. 2013;9(6):e1003407. (PMID: 23762029)
J Immunol. 2021 Jul 1;207(1):221-233. (PMID: 34183369)
Scand J Immunol. 2015 Jan;81(1):46-55. (PMID: 25359607)
BMC Med Genet. 2013 Apr 23;14:47. (PMID: 23617307)
J Immunol. 2000 Sep 1;165(5):2596-602. (PMID: 10946287)
Int Immunopharmacol. 2022 Nov;112:109238. (PMID: 36116151)
Cell Rep. 2017 Oct 3;21(1):126-140. (PMID: 28978467)
Nat Rev Immunol. 2019 Mar;19(3):184-197. (PMID: 30718831)
Nanomaterials (Basel). 2015 Dec 17;5(4):2317-2334. (PMID: 28347123)
Cell. 2011 Nov 11;147(4):868-80. (PMID: 22078883)
Cell Host Microbe. 2020 Feb 12;27(2):238-248.e7. (PMID: 31901518)
Dev Comp Immunol. 2014 Dec;47(2):223-33. (PMID: 25086293)
Int Immunol. 2012 Oct;24(10):637-44. (PMID: 22695634)
Cell Host Microbe. 2018 Sep 12;24(3):439-446.e4. (PMID: 30146391)
Cytokine. 2018 Apr;104:104-109. (PMID: 29046251)
J Leukoc Biol. 2009 Dec;86(6):1393-401. (PMID: 19773555)
فهرسة مساهمة: Keywords: Cytokines; Inflammasome; Mycobacterium tuberculosis; Pattern recognition receptor; Phagocytosis
تواريخ الأحداث: Date Created: 20231016 Latest Revision: 20231020
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC10570006
DOI: 10.1016/j.heliyon.2023.e20636
PMID: 37842564
قاعدة البيانات: MEDLINE
الوصف
تدمد:2405-8440
DOI:10.1016/j.heliyon.2023.e20636